This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Dec 6;29(52):9582.

doi: 10.1016/j.vaccine.2011.04.085. Epub 2011 May 11.

HLA-A2-restricted survivin-derived T-cell responses

Per Thor Straten, Mads Hald Andersen

PMID: 21569816
DOI: 10.1016/j.vaccine.2011.04.085

Comment

HLA-A2-restricted survivin-derived T-cell responses

Per Thor Straten et al. Vaccine. 2011.

. 2011 Dec 6;29(52):9582.

doi: 10.1016/j.vaccine.2011.04.085. Epub 2011 May 11.

Authors

Per Thor Straten, Mads Hald Andersen

PMID: 21569816
DOI: 10.1016/j.vaccine.2011.04.085

No abstract available

PubMed Disclaimer

Comment on

Altered decamer and nonamer from an HLA-A0201-restricted epitope of Survivin differentially stimulate T-cell responses in different individuals.
Bernatchez C, Zhu K, Li Y, Andersson H, Ionnides C, Fernandez-Vina M, Cano P, Cooper L, Abbruzzese J, Hwu P, Chang DZ, Radvanyi LG. Bernatchez C, et al. Vaccine. 2011 Apr 5;29(16):3021-30. doi: 10.1016/j.vaccine.2011.01.115. Epub 2011 Feb 12. Vaccine. 2011. PMID: 21320548 Free PMC article.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Research Materials
- NCI CPTC Antibody Characterization Program